1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > 2015 Tumor Marker Testing Market: Strategic Assessments of Current and Emerging Competitors

This new 80-page report from VPGMarketResearch.com provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include:
  • Sales
  • Product portfolios
  • Distribution tactics
  • Technological know-how
  • New products in R&D
  • Collaborative arrangements
  • Business strategies.

Contains 80 pages

This new 80-page report from VPGMarketResearch.com provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include:
  • Sales
  • Product portfolios
  • Distribution tactics
  • Technological know-how
  • New products in R&D
  • Collaborative arrangements
  • Business strategies.

    Table Of Contents

    2015 Tumor Marker Testing Market: Strategic Assessments of Current and Emerging Competitors
    LEADING TUMOR MARKER DIAGNOSTICS MARKET PLAYERS
    Strategic Assessments of Major Suppliers
    And Emerging Market Entrants
    Table of Contents

    - Abbott
    - AdnaGen/Alere
    - Agilent Technologies
    - Applied Gene Technologies
    - Arca Biopharma
    - Beckman Coulter/Danaher
    - Becton Dickinson
    - Biomedical Diagnostics
    - bioMerieux
    - Bio-Rad
    - CellSearch
    - Cepheid
    - Correlogic Systems/Vermillion
    - Decode Genetics
    - Diadexus
    - Diagnocure
    - Diasorin
    - Eiken Chemical
    - Elitech Group
    - Epigenomics
    - Enterix
    - Enzo Biochem
    - Exact Sciences
    - Fujirebio
    - Guided Therapeutics
    - Hologic/Gen-Probe
    - Kreatech/Leica
    - Kyowa Medex
    - Mackay Life Sciences
    - Myriad Genetics
    - OncoLab
    - Ortho-Clinical Diagnostics
    - Panacea Pharmaceuticals
    - Polartechnics
    - Polymedco
    Table of Contents
    - PreMD
    - Qiagen
    - Quest Diagnostics
    - Radient Pharmaceuticals
    - Roche
    - Scienion
    - Sequenom
    - Siemens Healthcare
    - Takara Bio
    - Targeted Diagnostics and Therapeutics
    - Thermo Fisher
    - Tosoh
    - Veridex
    - Wako Pure Chemicals
    - Wallac/PE
    - Zila

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 Europe Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 Europe Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 36000
  • Industry report
  • February 2017
  • by Venture Planning Group

This new 31-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as ...

Cancer Diagnostics 2017-2021: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Cancer Diagnostics 2017-2021: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 21100
  • Industry report
  • December 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. The report is available by country, section, market segment, and can be custom-tailored to your specific information ...

2017 Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

2017 Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...


Download Unlimited Documents from Trusted Public Sources

Diagnostics Forecast in the US

  • February 2017
    2 pages
  • Diagnostics  

    Cancer  

    Health Care Pro...  

  • United States  

View report >

The future of the Clinical Trial Industry in the US

  • January 2017
    2 pages
  • Clinical Trial  

    Genome Sequenci...  

    Biopsy  

  • United States  

View report >

Diagnostics Market Forecast in the US

  • January 2017
  • Diagnostics  

  • United States  

View report >

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.